#	Pagina
attuale pagina	/open-h2020/projects/227073/index.html

Opendata, web and dolomites

EndoSolve SIGNED

A novel medical device for the treatment of Endometriosis

Total Cost €

EC-Contrib. €

Partnership

Views

EndoSolve project word cloud

Explore the words cloud of the EndoSolve project. It provides you a very rough idea of what is the project "EndoSolve" about.

mechanism estrogen desire endosolve lesions forms correct pharma 10 children endometrial diagnostic uterus impactful group delay underlying fact physical women lack invasive device million disorders infertility pregnancy pain treat 11 medical undertreated disorder ing tissue expensive reference recurrence dependent risks made reproductive laparoscopy therapies symptom mental permanent disease reduce goals standard prevalent age outside 176 exacerbated worldwide first endometriosis diagnosis presentation treatment rate social delays cure chronic

Project "EndoSolve" data sheet

The following table provides information about the project.

Coordinator	NATIONAL UNIVERSITY OF IRELAND GALWAY Organization address address: UNIVERSITY ROAD city: Galway postcode: H91 website: www.nuigalway.ie contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Ireland [IE]
Total cost	0 €
EC max contribution	150˙000 € (0%)
Programme	1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
Code Call	ERC-2019-PoC
Funding Scheme	ERC-POC-LS
Starting year	2021
Duration (year-month-day)	from 2021-01-01 to 2021-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	NATIONAL UNIVERSITY OF IRELAND GALWAY NATIONAL UNIVERSITY OF IRELAND GALWAY Organization address address: UNIVERSITY ROAD city: Galway postcode: H91 website: www.nuigalway.ie contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IE (Galway)	coordinator	150˙000.00

Map

Project objective

Endometriosis is one of the most prevalent, impactful and undertreated disorders to affect European women. The condition is defined as an estrogen-dependent disorder, where endometrial tissue forms lesions outside the uterus resulting in chronic pain and infertility. Endometriosis affects an estimated 10% of European women in the reproductive-age group (176 million women worldwide and 10.7 million in the EU) with significant impact on their physical, mental, and social well-being (This impact is exacerbated by the fact that the correct diagnosis is made as late as 8–11 years after symptom presentation. Treatment delays are due to a lack of a reliable non-invasive diagnostic test, and the fact that the reference diagnostic standard is laparoscopy (invasive, expensive and not without risks). As there is no permanent cure for endometriosis, current therapies have three main goals: (i) to reduce pain; (ii) to increase the pregnancy rate for women who desire to have children and (iii) to delay recurrence for as long as possible. The EndoSolve project will develop the first medical device to treat the underlying mechanism of endometriosis, providing a long-term non-pharma treatment for the chronic disease.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ENDOSOLVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ENDOSOLVE" are provided by the European Opendata Portal: CORDIS opendata.